nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—urinary bladder cancer	0.24	0.563	CbGaD
Zidovudine—UGT2B7—urinary bladder cancer	0.186	0.438	CbGaD
Zidovudine—SLC28A1—Gemcitabine—urinary bladder cancer	0.109	0.273	CbGbCtD
Zidovudine—SLC29A2—Gemcitabine—urinary bladder cancer	0.0725	0.181	CbGbCtD
Zidovudine—ABCC5—Fluorouracil—urinary bladder cancer	0.0272	0.068	CbGbCtD
Zidovudine—ABCC5—Cisplatin—urinary bladder cancer	0.0231	0.0578	CbGbCtD
Zidovudine—UGT2B7—Epirubicin—urinary bladder cancer	0.0159	0.0396	CbGbCtD
Zidovudine—SLC22A7—Fluorouracil—urinary bladder cancer	0.0134	0.0335	CbGbCtD
Zidovudine—ABCC4—Fluorouracil—urinary bladder cancer	0.0131	0.0327	CbGbCtD
Zidovudine—ABCB1—Mitomycin—urinary bladder cancer	0.0103	0.0257	CbGbCtD
Zidovudine—SLC22A2—Cisplatin—urinary bladder cancer	0.00809	0.0202	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—urinary bladder cancer	0.00775	0.0194	CbGbCtD
Zidovudine—CYP2A6—Fluorouracil—urinary bladder cancer	0.0076	0.019	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—urinary bladder cancer	0.00738	0.0184	CbGbCtD
Zidovudine—ABCC4—Methotrexate—urinary bladder cancer	0.00721	0.018	CbGbCtD
Zidovudine—ABCG2—Fluorouracil—urinary bladder cancer	0.00703	0.0176	CbGbCtD
Zidovudine—ABCG2—Carboplatin—urinary bladder cancer	0.00699	0.0175	CbGbCtD
Zidovudine—ABCG2—Cisplatin—urinary bladder cancer	0.00598	0.0149	CbGbCtD
Zidovudine—ABCG2—Etoposide—urinary bladder cancer	0.00587	0.0147	CbGbCtD
Zidovudine—ALB—Fluorouracil—urinary bladder cancer	0.00485	0.0121	CbGbCtD
Zidovudine—CYP3A4—Thiotepa—urinary bladder cancer	0.00468	0.0117	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—urinary bladder cancer	0.00451	0.0113	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—urinary bladder cancer	0.004	0.01	CbGbCtD
Zidovudine—ABCG2—Methotrexate—urinary bladder cancer	0.00388	0.00969	CbGbCtD
Zidovudine—CYP2C8—Fluorouracil—urinary bladder cancer	0.00375	0.00936	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—urinary bladder cancer	0.00314	0.00784	CbGbCtD
Zidovudine—CYP2C8—Etoposide—urinary bladder cancer	0.00313	0.00781	CbGbCtD
Zidovudine—ABCB1—Gemcitabine—urinary bladder cancer	0.00297	0.00741	CbGbCtD
Zidovudine—ALB—Methotrexate—urinary bladder cancer	0.00267	0.00668	CbGbCtD
Zidovudine—CYP2C9—Fluorouracil—urinary bladder cancer	0.00261	0.00653	CbGbCtD
Zidovudine—TERT—prostate gland—urinary bladder cancer	0.00255	0.0774	CbGeAlD
Zidovudine—CYP2C9—Cisplatin—urinary bladder cancer	0.00222	0.00555	CbGbCtD
Zidovudine—ABCB1—Cisplatin—urinary bladder cancer	0.00215	0.00538	CbGbCtD
Zidovudine—ABCB1—Etoposide—urinary bladder cancer	0.00212	0.00529	CbGbCtD
Zidovudine—TERT—epithelium—urinary bladder cancer	0.00187	0.0569	CbGeAlD
Zidovudine—SLC28A1—renal system—urinary bladder cancer	0.00177	0.0537	CbGeAlD
Zidovudine—SLC22A8—urine—urinary bladder cancer	0.0015	0.0456	CbGeAlD
Zidovudine—SLC29A2—prostate gland—urinary bladder cancer	0.00145	0.044	CbGeAlD
Zidovudine—ABCB1—Doxorubicin—urinary bladder cancer	0.00144	0.00361	CbGbCtD
Zidovudine—ABCB1—Methotrexate—urinary bladder cancer	0.0014	0.00349	CbGbCtD
Zidovudine—TERT—female reproductive system—urinary bladder cancer	0.00139	0.0422	CbGeAlD
Zidovudine—Floxuridine—TYMP—urinary bladder cancer	0.00135	0.379	CrCbGaD
Zidovudine—TK1—epithelium—urinary bladder cancer	0.00129	0.0391	CbGeAlD
Zidovudine—CYP3A4—Etoposide—urinary bladder cancer	0.00127	0.00317	CbGbCtD
Zidovudine—CYP2C19—urine—urinary bladder cancer	0.00126	0.0382	CbGeAlD
Zidovudine—Trifluridine—TYMP—urinary bladder cancer	0.00107	0.301	CrCbGaD
Zidovudine—UGT2B7—prostate gland—urinary bladder cancer	0.000979	0.0298	CbGeAlD
Zidovudine—CYP2C9—urine—urinary bladder cancer	0.000975	0.0296	CbGeAlD
Zidovudine—TK1—female reproductive system—urinary bladder cancer	0.000957	0.0291	CbGeAlD
Zidovudine—TK1—Azacitidine—Gemcitabine—urinary bladder cancer	0.000955	1	CbGdCrCtD
Zidovudine—TK1—vagina—urinary bladder cancer	0.000865	0.0263	CbGeAlD
Zidovudine—CYP3A4—Doxorubicin—urinary bladder cancer	0.000865	0.00216	CbGbCtD
Zidovudine—SLC29A2—female reproductive system—urinary bladder cancer	0.000791	0.024	CbGeAlD
Zidovudine—ABCC5—prostate gland—urinary bladder cancer	0.000783	0.0238	CbGeAlD
Zidovudine—CYP3A4—urine—urinary bladder cancer	0.000743	0.0226	CbGeAlD
Zidovudine—SLC29A2—vagina—urinary bladder cancer	0.000716	0.0217	CbGeAlD
Zidovudine—CYP2A6—prostate gland—urinary bladder cancer	0.000702	0.0213	CbGeAlD
Zidovudine—UGT2B7—renal system—urinary bladder cancer	0.000667	0.0203	CbGeAlD
Zidovudine—SLC22A11—renal system—urinary bladder cancer	0.00065	0.0198	CbGeAlD
Zidovudine—Floxuridine—TYMS—urinary bladder cancer	0.000636	0.178	CrCbGaD
Zidovudine—SLC22A7—renal system—urinary bladder cancer	0.000635	0.0193	CbGeAlD
Zidovudine—CYP2A6—seminal vesicle—urinary bladder cancer	0.000594	0.018	CbGeAlD
Zidovudine—SLC22A2—renal system—urinary bladder cancer	0.000565	0.0172	CbGeAlD
Zidovudine—TK1—lymph node—urinary bladder cancer	0.00056	0.017	CbGeAlD
Zidovudine—ABCC4—prostate gland—urinary bladder cancer	0.000543	0.0165	CbGeAlD
Zidovudine—SLC22A8—prostate gland—urinary bladder cancer	0.000538	0.0164	CbGeAlD
Zidovudine—UGT2B7—female reproductive system—urinary bladder cancer	0.000535	0.0162	CbGeAlD
Zidovudine—SLC22A11—female reproductive system—urinary bladder cancer	0.000521	0.0158	CbGeAlD
Zidovudine—Trifluridine—TYMS—urinary bladder cancer	0.000505	0.142	CrCbGaD
Zidovudine—SLC29A2—lymph node—urinary bladder cancer	0.000463	0.0141	CbGeAlD
Zidovudine—ABCC5—vagina—urinary bladder cancer	0.000386	0.0117	CbGeAlD
Zidovudine—ABCG2—prostate gland—urinary bladder cancer	0.000383	0.0116	CbGeAlD
Zidovudine—ABCC4—renal system—urinary bladder cancer	0.00037	0.0112	CbGeAlD
Zidovudine—SLC22A8—renal system—urinary bladder cancer	0.000367	0.0111	CbGeAlD
Zidovudine—CYP2A6—vagina—urinary bladder cancer	0.000346	0.0105	CbGeAlD
Zidovudine—ABCG2—seminal vesicle—urinary bladder cancer	0.000324	0.00984	CbGeAlD
Zidovudine—ABCC4—female reproductive system—urinary bladder cancer	0.000296	0.009	CbGeAlD
Zidovudine—CYP2C8—renal system—urinary bladder cancer	0.000268	0.00816	CbGeAlD
Zidovudine—ABCG2—urethra—urinary bladder cancer	0.000256	0.00779	CbGeAlD
Zidovudine—ABCC5—lymph node—urinary bladder cancer	0.00025	0.00759	CbGeAlD
Zidovudine—CYP2C19—vagina—urinary bladder cancer	0.000223	0.00677	CbGeAlD
Zidovudine—CYP2C8—female reproductive system—urinary bladder cancer	0.000215	0.00653	CbGeAlD
Zidovudine—CYP2C8—vagina—urinary bladder cancer	0.000194	0.00591	CbGeAlD
Zidovudine—CYP2C9—female reproductive system—urinary bladder cancer	0.000191	0.0058	CbGeAlD
Zidovudine—ABCG2—vagina—urinary bladder cancer	0.000189	0.00575	CbGeAlD
Zidovudine—ABCB1—prostate gland—urinary bladder cancer	0.000189	0.00574	CbGeAlD
Zidovudine—CYP3A4—renal system—urinary bladder cancer	0.000182	0.00553	CbGeAlD
Zidovudine—ALB—lymph node—urinary bladder cancer	0.000179	0.00544	CbGeAlD
Zidovudine—ABCC4—lymph node—urinary bladder cancer	0.000173	0.00526	CbGeAlD
Zidovudine—ABCB1—seminal vesicle—urinary bladder cancer	0.00016	0.00485	CbGeAlD
Zidovudine—CYP3A4—female reproductive system—urinary bladder cancer	0.000146	0.00443	CbGeAlD
Zidovudine—ABCB1—epithelium—urinary bladder cancer	0.000139	0.00422	CbGeAlD
Zidovudine—ABCB1—renal system—urinary bladder cancer	0.000129	0.00391	CbGeAlD
Zidovudine—ABCB1—urethra—urinary bladder cancer	0.000126	0.00384	CbGeAlD
Zidovudine—ABCG2—lymph node—urinary bladder cancer	0.000122	0.00372	CbGeAlD
Zidovudine—ABCB1—female reproductive system—urinary bladder cancer	0.000103	0.00313	CbGeAlD
Zidovudine—ABCB1—vagina—urinary bladder cancer	9.32e-05	0.00283	CbGeAlD
Zidovudine—ABCB1—lymph node—urinary bladder cancer	6.03e-05	0.00183	CbGeAlD
Zidovudine—Constipation—Etoposide—urinary bladder cancer	5.32e-05	0.000681	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—urinary bladder cancer	5.3e-05	0.000679	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—urinary bladder cancer	5.3e-05	0.000679	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—urinary bladder cancer	5.24e-05	0.000672	CcSEcCtD
Zidovudine—Sweating—Epirubicin—urinary bladder cancer	5.24e-05	0.000671	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—urinary bladder cancer	5.24e-05	0.000671	CcSEcCtD
Zidovudine—Asthenia—Gemcitabine—urinary bladder cancer	5.23e-05	0.000669	CcSEcCtD
Zidovudine—Haematuria—Epirubicin—urinary bladder cancer	5.21e-05	0.000668	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—urinary bladder cancer	5.2e-05	0.000667	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—urinary bladder cancer	5.18e-05	0.000663	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	5.17e-05	0.000662	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—urinary bladder cancer	5.16e-05	0.00066	CcSEcCtD
Zidovudine—Pruritus—Gemcitabine—urinary bladder cancer	5.15e-05	0.00066	CcSEcCtD
Zidovudine—Nausea—Thiotepa—urinary bladder cancer	5.14e-05	0.000659	CcSEcCtD
Zidovudine—Urethral disorder—Methotrexate—urinary bladder cancer	5.14e-05	0.000658	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—urinary bladder cancer	5.13e-05	0.000657	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—urinary bladder cancer	5.13e-05	0.000657	CcSEcCtD
Zidovudine—Feeling abnormal—Etoposide—urinary bladder cancer	5.13e-05	0.000656	CcSEcCtD
Zidovudine—Agranulocytosis—Epirubicin—urinary bladder cancer	5.1e-05	0.000653	CcSEcCtD
Zidovudine—Gastrointestinal pain—Etoposide—urinary bladder cancer	5.09e-05	0.000651	CcSEcCtD
Zidovudine—Pruritus—Fluorouracil—urinary bladder cancer	5.07e-05	0.000649	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	5.01e-05	0.000642	CcSEcCtD
Zidovudine—Diarrhoea—Gemcitabine—urinary bladder cancer	4.98e-05	0.000638	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—urinary bladder cancer	4.96e-05	0.000635	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	4.96e-05	0.000635	CcSEcCtD
Zidovudine—Urticaria—Etoposide—urinary bladder cancer	4.94e-05	0.000633	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—urinary bladder cancer	4.93e-05	0.000631	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—urinary bladder cancer	4.93e-05	0.000631	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—urinary bladder cancer	4.92e-05	0.00063	CcSEcCtD
Zidovudine—Abdominal pain—Etoposide—urinary bladder cancer	4.92e-05	0.00063	CcSEcCtD
Zidovudine—Body temperature increased—Etoposide—urinary bladder cancer	4.92e-05	0.00063	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—urinary bladder cancer	4.91e-05	0.000629	CcSEcCtD
Zidovudine—Diarrhoea—Fluorouracil—urinary bladder cancer	4.9e-05	0.000628	CcSEcCtD
Zidovudine—Asthenia—Cisplatin—urinary bladder cancer	4.87e-05	0.000624	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—urinary bladder cancer	4.87e-05	0.000624	CcSEcCtD
Zidovudine—Cardiac disorder—Methotrexate—urinary bladder cancer	4.87e-05	0.000623	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—urinary bladder cancer	4.85e-05	0.000621	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—urinary bladder cancer	4.85e-05	0.000621	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—urinary bladder cancer	4.82e-05	0.000618	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—urinary bladder cancer	4.82e-05	0.000618	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—urinary bladder cancer	4.81e-05	0.000616	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	4.78e-05	0.000613	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—urinary bladder cancer	4.77e-05	0.000611	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—urinary bladder cancer	4.75e-05	0.000608	CcSEcCtD
Zidovudine—Dizziness—Fluorouracil—urinary bladder cancer	4.74e-05	0.000607	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—urinary bladder cancer	4.73e-05	0.000605	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—urinary bladder cancer	4.72e-05	0.000605	CcSEcCtD
Zidovudine—Chills—Methotrexate—urinary bladder cancer	4.71e-05	0.000603	CcSEcCtD
Zidovudine—Diarrhoea—Cisplatin—urinary bladder cancer	4.65e-05	0.000595	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—urinary bladder cancer	4.64e-05	0.000594	CcSEcCtD
Zidovudine—Vomiting—Gemcitabine—urinary bladder cancer	4.63e-05	0.000593	CcSEcCtD
Zidovudine—Mental disorder—Methotrexate—urinary bladder cancer	4.59e-05	0.000588	CcSEcCtD
Zidovudine—Rash—Gemcitabine—urinary bladder cancer	4.59e-05	0.000588	CcSEcCtD
Zidovudine—Dermatitis—Gemcitabine—urinary bladder cancer	4.59e-05	0.000588	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—urinary bladder cancer	4.56e-05	0.000585	CcSEcCtD
Zidovudine—Erythema—Methotrexate—urinary bladder cancer	4.56e-05	0.000585	CcSEcCtD
Zidovudine—Headache—Gemcitabine—urinary bladder cancer	4.56e-05	0.000584	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—urinary bladder cancer	4.55e-05	0.000583	CcSEcCtD
Zidovudine—Vomiting—Fluorouracil—urinary bladder cancer	4.55e-05	0.000583	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—urinary bladder cancer	4.55e-05	0.000583	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—urinary bladder cancer	4.54e-05	0.000582	CcSEcCtD
Zidovudine—Rash—Fluorouracil—urinary bladder cancer	4.52e-05	0.000578	CcSEcCtD
Zidovudine—Dermatitis—Fluorouracil—urinary bladder cancer	4.51e-05	0.000578	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—urinary bladder cancer	4.51e-05	0.000577	CcSEcCtD
Zidovudine—Headache—Fluorouracil—urinary bladder cancer	4.49e-05	0.000575	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	4.48e-05	0.000574	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—urinary bladder cancer	4.47e-05	0.000573	CcSEcCtD
Zidovudine—Asthenia—Etoposide—urinary bladder cancer	4.46e-05	0.000572	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	4.46e-05	0.000571	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—urinary bladder cancer	4.45e-05	0.00057	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—urinary bladder cancer	4.42e-05	0.000566	CcSEcCtD
Zidovudine—Back pain—Methotrexate—urinary bladder cancer	4.42e-05	0.000566	CcSEcCtD
Zidovudine—Chills—Epirubicin—urinary bladder cancer	4.4e-05	0.000564	CcSEcCtD
Zidovudine—Pruritus—Etoposide—urinary bladder cancer	4.4e-05	0.000564	CcSEcCtD
Zidovudine—Nausea—Gemcitabine—urinary bladder cancer	4.33e-05	0.000554	CcSEcCtD
Zidovudine—Vomiting—Cisplatin—urinary bladder cancer	4.32e-05	0.000553	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—urinary bladder cancer	4.3e-05	0.000551	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—urinary bladder cancer	4.29e-05	0.00055	CcSEcCtD
Zidovudine—Rash—Cisplatin—urinary bladder cancer	4.28e-05	0.000548	CcSEcCtD
Zidovudine—Dermatitis—Cisplatin—urinary bladder cancer	4.28e-05	0.000548	CcSEcCtD
Zidovudine—Erythema—Epirubicin—urinary bladder cancer	4.27e-05	0.000547	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—urinary bladder cancer	4.27e-05	0.000547	CcSEcCtD
Zidovudine—Diarrhoea—Etoposide—urinary bladder cancer	4.26e-05	0.000545	CcSEcCtD
Zidovudine—Nausea—Fluorouracil—urinary bladder cancer	4.25e-05	0.000545	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.24e-05	0.000542	CcSEcCtD
Zidovudine—Anaemia—Methotrexate—urinary bladder cancer	4.22e-05	0.00054	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—urinary bladder cancer	4.21e-05	0.00054	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—urinary bladder cancer	4.21e-05	0.000539	CcSEcCtD
Zidovudine—Tension—Epirubicin—urinary bladder cancer	4.19e-05	0.000537	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—urinary bladder cancer	4.18e-05	0.000536	CcSEcCtD
Zidovudine—Nervousness—Epirubicin—urinary bladder cancer	4.15e-05	0.000531	CcSEcCtD
Zidovudine—Back pain—Epirubicin—urinary bladder cancer	4.13e-05	0.000529	CcSEcCtD
Zidovudine—Malaise—Methotrexate—urinary bladder cancer	4.12e-05	0.000527	CcSEcCtD
Zidovudine—Dizziness—Etoposide—urinary bladder cancer	4.11e-05	0.000527	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—urinary bladder cancer	4.11e-05	0.000526	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—urinary bladder cancer	4.1e-05	0.000525	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	4.09e-05	0.000524	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—urinary bladder cancer	4.09e-05	0.000523	CcSEcCtD
Zidovudine—Chills—Doxorubicin—urinary bladder cancer	4.07e-05	0.000522	CcSEcCtD
Zidovudine—Nausea—Cisplatin—urinary bladder cancer	4.03e-05	0.000516	CcSEcCtD
Zidovudine—Cough—Methotrexate—urinary bladder cancer	3.98e-05	0.00051	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—urinary bladder cancer	3.98e-05	0.000509	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.96e-05	0.000508	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—urinary bladder cancer	3.95e-05	0.000507	CcSEcCtD
Zidovudine—Vomiting—Etoposide—urinary bladder cancer	3.95e-05	0.000506	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—urinary bladder cancer	3.95e-05	0.000506	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—urinary bladder cancer	3.95e-05	0.000506	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—urinary bladder cancer	3.95e-05	0.000506	CcSEcCtD
Zidovudine—Rash—Etoposide—urinary bladder cancer	3.92e-05	0.000502	CcSEcCtD
Zidovudine—Dermatitis—Etoposide—urinary bladder cancer	3.92e-05	0.000502	CcSEcCtD
Zidovudine—Headache—Etoposide—urinary bladder cancer	3.9e-05	0.000499	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—urinary bladder cancer	3.89e-05	0.000499	CcSEcCtD
Zidovudine—Arthralgia—Methotrexate—urinary bladder cancer	3.89e-05	0.000498	CcSEcCtD
Zidovudine—Myalgia—Methotrexate—urinary bladder cancer	3.89e-05	0.000498	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—urinary bladder cancer	3.89e-05	0.000498	CcSEcCtD
Zidovudine—Tension—Doxorubicin—urinary bladder cancer	3.88e-05	0.000497	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—urinary bladder cancer	3.87e-05	0.000496	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.86e-05	0.000494	CcSEcCtD
Zidovudine—Malaise—Epirubicin—urinary bladder cancer	3.85e-05	0.000493	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—urinary bladder cancer	3.84e-05	0.000492	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—urinary bladder cancer	3.84e-05	0.000492	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—urinary bladder cancer	3.84e-05	0.000492	CcSEcCtD
Zidovudine—Syncope—Epirubicin—urinary bladder cancer	3.83e-05	0.000491	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—urinary bladder cancer	3.82e-05	0.00049	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—urinary bladder cancer	3.82e-05	0.00049	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—urinary bladder cancer	3.8e-05	0.000487	CcSEcCtD
Zidovudine—Confusional state—Methotrexate—urinary bladder cancer	3.76e-05	0.000481	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—urinary bladder cancer	3.75e-05	0.000481	CcSEcCtD
Zidovudine—Cough—Epirubicin—urinary bladder cancer	3.73e-05	0.000477	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.73e-05	0.000477	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—urinary bladder cancer	3.7e-05	0.000474	CcSEcCtD
Zidovudine—Nausea—Etoposide—urinary bladder cancer	3.69e-05	0.000473	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.67e-05	0.00047	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—urinary bladder cancer	3.65e-05	0.000468	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—urinary bladder cancer	3.65e-05	0.000468	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.65e-05	0.000467	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—urinary bladder cancer	3.64e-05	0.000466	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—urinary bladder cancer	3.64e-05	0.000466	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—urinary bladder cancer	3.64e-05	0.000466	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—urinary bladder cancer	3.62e-05	0.000464	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—urinary bladder cancer	3.62e-05	0.000463	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.61e-05	0.000463	CcSEcCtD
Zidovudine—Hyperhidrosis—Methotrexate—urinary bladder cancer	3.6e-05	0.000461	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—urinary bladder cancer	3.59e-05	0.00046	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—urinary bladder cancer	3.56e-05	0.000457	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—urinary bladder cancer	3.55e-05	0.000455	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—urinary bladder cancer	3.55e-05	0.000455	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—urinary bladder cancer	3.54e-05	0.000454	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—urinary bladder cancer	3.54e-05	0.000453	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—urinary bladder cancer	3.52e-05	0.00045	CcSEcCtD
Zidovudine—Oedema—Epirubicin—urinary bladder cancer	3.49e-05	0.000447	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.49e-05	0.000447	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.47e-05	0.000445	CcSEcCtD
Zidovudine—Cough—Doxorubicin—urinary bladder cancer	3.45e-05	0.000442	CcSEcCtD
Zidovudine—Shock—Epirubicin—urinary bladder cancer	3.43e-05	0.000439	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—urinary bladder cancer	3.42e-05	0.000439	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—urinary bladder cancer	3.42e-05	0.000438	CcSEcCtD
Zidovudine—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.41e-05	0.000437	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.39e-05	0.000435	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—urinary bladder cancer	3.39e-05	0.000434	CcSEcCtD
Zidovudine—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.37e-05	0.000432	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—urinary bladder cancer	3.37e-05	0.000432	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—urinary bladder cancer	3.37e-05	0.000431	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—urinary bladder cancer	3.37e-05	0.000431	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—urinary bladder cancer	3.37e-05	0.000431	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—urinary bladder cancer	3.35e-05	0.00043	CcSEcCtD
Zidovudine—Paraesthesia—Methotrexate—urinary bladder cancer	3.35e-05	0.000428	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.34e-05	0.000428	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—urinary bladder cancer	3.32e-05	0.000426	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—urinary bladder cancer	3.32e-05	0.000426	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—urinary bladder cancer	3.32e-05	0.000425	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—urinary bladder cancer	3.31e-05	0.000424	CcSEcCtD
Zidovudine—Dyspepsia—Methotrexate—urinary bladder cancer	3.28e-05	0.00042	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—urinary bladder cancer	3.25e-05	0.000417	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—urinary bladder cancer	3.24e-05	0.000415	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.23e-05	0.000413	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—urinary bladder cancer	3.23e-05	0.000413	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.22e-05	0.000412	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—urinary bladder cancer	3.21e-05	0.000411	CcSEcCtD
Zidovudine—Pain—Methotrexate—urinary bladder cancer	3.19e-05	0.000408	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.18e-05	0.000407	CcSEcCtD
Zidovudine—Shock—Doxorubicin—urinary bladder cancer	3.17e-05	0.000406	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.16e-05	0.000405	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.16e-05	0.000405	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—urinary bladder cancer	3.15e-05	0.000404	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—urinary bladder cancer	3.13e-05	0.000401	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—urinary bladder cancer	3.13e-05	0.000401	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.12e-05	0.000399	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—urinary bladder cancer	3.11e-05	0.000398	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—urinary bladder cancer	3.1e-05	0.000397	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—urinary bladder cancer	3.07e-05	0.000394	CcSEcCtD
Zidovudine—Feeling abnormal—Methotrexate—urinary bladder cancer	3.07e-05	0.000393	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—urinary bladder cancer	3.07e-05	0.000393	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.05e-05	0.00039	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—urinary bladder cancer	3.03e-05	0.000388	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.01e-05	0.000386	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—urinary bladder cancer	3.01e-05	0.000385	CcSEcCtD
Zidovudine—Pain—Epirubicin—urinary bladder cancer	2.98e-05	0.000382	CcSEcCtD
Zidovudine—Constipation—Epirubicin—urinary bladder cancer	2.98e-05	0.000382	CcSEcCtD
Zidovudine—Urticaria—Methotrexate—urinary bladder cancer	2.96e-05	0.000379	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—urinary bladder cancer	2.95e-05	0.000377	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—urinary bladder cancer	2.95e-05	0.000377	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.94e-05	0.000376	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—urinary bladder cancer	2.92e-05	0.000374	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—urinary bladder cancer	2.9e-05	0.000371	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—urinary bladder cancer	2.88e-05	0.000368	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—urinary bladder cancer	2.87e-05	0.000368	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—urinary bladder cancer	2.87e-05	0.000367	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.85e-05	0.000365	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—urinary bladder cancer	2.84e-05	0.000364	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—urinary bladder cancer	2.8e-05	0.000359	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.78e-05	0.000357	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—urinary bladder cancer	2.78e-05	0.000356	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—urinary bladder cancer	2.77e-05	0.000355	CcSEcCtD
Zidovudine—Pain—Doxorubicin—urinary bladder cancer	2.76e-05	0.000353	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—urinary bladder cancer	2.76e-05	0.000353	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—urinary bladder cancer	2.76e-05	0.000353	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—urinary bladder cancer	2.76e-05	0.000353	CcSEcCtD
Zidovudine—Asthenia—Methotrexate—urinary bladder cancer	2.67e-05	0.000342	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.66e-05	0.00034	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.64e-05	0.000338	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—urinary bladder cancer	2.64e-05	0.000338	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—urinary bladder cancer	2.56e-05	0.000328	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—urinary bladder cancer	2.55e-05	0.000327	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—urinary bladder cancer	2.55e-05	0.000327	CcSEcCtD
Zidovudine—Diarrhoea—Methotrexate—urinary bladder cancer	2.55e-05	0.000326	CcSEcCtD
Zidovudine—Asthenia—Epirubicin—urinary bladder cancer	2.5e-05	0.00032	CcSEcCtD
Zidovudine—Pruritus—Epirubicin—urinary bladder cancer	2.47e-05	0.000316	CcSEcCtD
Zidovudine—Dizziness—Methotrexate—urinary bladder cancer	2.46e-05	0.000316	CcSEcCtD
Zidovudine—Diarrhoea—Epirubicin—urinary bladder cancer	2.39e-05	0.000306	CcSEcCtD
Zidovudine—Vomiting—Methotrexate—urinary bladder cancer	2.37e-05	0.000303	CcSEcCtD
Zidovudine—Rash—Methotrexate—urinary bladder cancer	2.35e-05	0.000301	CcSEcCtD
Zidovudine—Dermatitis—Methotrexate—urinary bladder cancer	2.35e-05	0.000301	CcSEcCtD
Zidovudine—Headache—Methotrexate—urinary bladder cancer	2.33e-05	0.000299	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—urinary bladder cancer	2.31e-05	0.000296	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—urinary bladder cancer	2.31e-05	0.000295	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—urinary bladder cancer	2.28e-05	0.000292	CcSEcCtD
Zidovudine—Vomiting—Epirubicin—urinary bladder cancer	2.22e-05	0.000284	CcSEcCtD
Zidovudine—Nausea—Methotrexate—urinary bladder cancer	2.21e-05	0.000283	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.21e-05	0.000283	CcSEcCtD
Zidovudine—Rash—Epirubicin—urinary bladder cancer	2.2e-05	0.000282	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—urinary bladder cancer	2.2e-05	0.000281	CcSEcCtD
Zidovudine—Headache—Epirubicin—urinary bladder cancer	2.18e-05	0.00028	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—urinary bladder cancer	2.13e-05	0.000273	CcSEcCtD
Zidovudine—Nausea—Epirubicin—urinary bladder cancer	2.07e-05	0.000265	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—urinary bladder cancer	2.05e-05	0.000263	CcSEcCtD
Zidovudine—Rash—Doxorubicin—urinary bladder cancer	2.03e-05	0.000261	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—urinary bladder cancer	2.03e-05	0.00026	CcSEcCtD
Zidovudine—Headache—Doxorubicin—urinary bladder cancer	2.02e-05	0.000259	CcSEcCtD
Zidovudine—Nausea—Doxorubicin—urinary bladder cancer	1.92e-05	0.000245	CcSEcCtD
Zidovudine—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	6.93e-06	0.000119	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.92e-06	0.000119	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—TYMS—urinary bladder cancer	6.91e-06	0.000119	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RHOA—urinary bladder cancer	6.89e-06	0.000119	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.85e-06	0.000118	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	6.84e-06	0.000118	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	6.83e-06	0.000118	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	6.83e-06	0.000118	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.75e-06	0.000116	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.73e-06	0.000116	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	6.72e-06	0.000116	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	6.66e-06	0.000115	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—urinary bladder cancer	6.64e-06	0.000114	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PPARG—urinary bladder cancer	6.64e-06	0.000114	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.56e-06	0.000113	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	6.54e-06	0.000113	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GPX1—urinary bladder cancer	6.54e-06	0.000113	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.53e-06	0.000112	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMP—urinary bladder cancer	6.51e-06	0.000112	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	6.42e-06	0.000111	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.42e-06	0.000111	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CREBBP—urinary bladder cancer	6.38e-06	0.00011	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB2—urinary bladder cancer	6.38e-06	0.00011	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	6.34e-06	0.000109	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.28e-06	0.000108	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.25e-06	0.000108	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.24e-06	0.000108	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—urinary bladder cancer	6.24e-06	0.000107	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NQO1—urinary bladder cancer	6.14e-06	0.000106	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.12e-06	0.000105	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NQO1—urinary bladder cancer	6.08e-06	0.000105	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	6.04e-06	0.000104	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLAU—urinary bladder cancer	5.98e-06	0.000103	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—urinary bladder cancer	5.98e-06	0.000103	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	5.94e-06	0.000102	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	5.92e-06	0.000102	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—urinary bladder cancer	5.91e-06	0.000102	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NAT2—urinary bladder cancer	5.88e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.86e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	5.84e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.8e-06	9.99e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.8e-06	9.99e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMP—urinary bladder cancer	5.7e-06	9.82e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—urinary bladder cancer	5.65e-06	9.73e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.61e-06	9.66e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.59e-06	9.64e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	5.58e-06	9.62e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.47e-06	9.43e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1A—urinary bladder cancer	5.45e-06	9.39e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTEN—urinary bladder cancer	5.44e-06	9.37e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.34e-06	9.2e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	5.33e-06	9.17e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—urinary bladder cancer	5.31e-06	9.16e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.3e-06	9.13e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	5.28e-06	9.1e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—urinary bladder cancer	5.22e-06	9e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.21e-06	8.98e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EP300—urinary bladder cancer	5.19e-06	8.94e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.17e-06	8.9e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.16e-06	8.88e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTP1—urinary bladder cancer	5.13e-06	8.83e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.12e-06	8.81e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.11e-06	8.8e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—urinary bladder cancer	5.08e-06	8.76e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—RRM2—urinary bladder cancer	5.08e-06	8.75e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	5.07e-06	8.74e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SRC—urinary bladder cancer	5.04e-06	8.69e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—CREBBP—urinary bladder cancer	4.93e-06	8.5e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—urinary bladder cancer	4.9e-06	8.43e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IGF1—urinary bladder cancer	4.87e-06	8.39e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.82e-06	8.3e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.77e-06	8.22e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TYMS—urinary bladder cancer	4.76e-06	8.21e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.73e-06	8.15e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.73e-06	8.15e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	4.72e-06	8.12e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NCOR1—urinary bladder cancer	4.71e-06	8.11e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTM1—urinary bladder cancer	4.71e-06	8.11e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ENO2—urinary bladder cancer	4.7e-06	8.1e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HPGDS—urinary bladder cancer	4.7e-06	8.1e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.7e-06	8.1e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	4.7e-06	8.1e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.68e-06	8.06e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	4.66e-06	8.03e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	4.66e-06	8.03e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	4.66e-06	8.02e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.59e-06	7.91e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	4.59e-06	7.9e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTT1—urinary bladder cancer	4.56e-06	7.86e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.56e-06	7.85e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTEN—urinary bladder cancer	4.56e-06	7.85e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—urinary bladder cancer	4.52e-06	7.79e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.52e-06	7.78e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GPX1—urinary bladder cancer	4.51e-06	7.77e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.51e-06	7.77e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.49e-06	7.74e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RHOA—urinary bladder cancer	4.46e-06	7.69e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	4.46e-06	7.69e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.45e-06	7.67e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ERCC2—urinary bladder cancer	4.43e-06	7.63e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—urinary bladder cancer	4.42e-06	7.62e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.39e-06	7.57e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	4.38e-06	7.55e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—EP300—urinary bladder cancer	4.34e-06	7.48e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	4.33e-06	7.46e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	4.28e-06	7.37e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	4.28e-06	7.37e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.27e-06	7.36e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.22e-06	7.27e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.22e-06	7.27e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.2e-06	7.23e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—urinary bladder cancer	4.18e-06	7.19e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—MTHFR—urinary bladder cancer	4.16e-06	7.17e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.16e-06	7.16e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.12e-06	7.1e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.12e-06	7.1e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	4.12e-06	7.1e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	4.1e-06	7.06e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.1e-06	7.05e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.03e-06	6.95e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	4.02e-06	6.93e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	4e-06	6.89e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	3.85e-06	6.63e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.85e-06	6.63e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.85e-06	6.63e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.83e-06	6.59e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.81e-06	6.57e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NQO1—urinary bladder cancer	3.79e-06	6.53e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	3.78e-06	6.51e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2—urinary bladder cancer	3.75e-06	6.45e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.74e-06	6.45e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.73e-06	6.43e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.7e-06	6.37e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.68e-06	6.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.68e-06	6.33e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—urinary bladder cancer	3.55e-06	6.12e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.51e-06	6.05e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.4e-06	5.86e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—urinary bladder cancer	3.38e-06	5.81e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EP300—urinary bladder cancer	3.36e-06	5.79e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTEN—urinary bladder cancer	3.36e-06	5.78e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	3.34e-06	5.75e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.32e-06	5.72e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.3e-06	5.69e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SRC—urinary bladder cancer	3.27e-06	5.63e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CREBBP—urinary bladder cancer	3.24e-06	5.59e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.23e-06	5.56e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	3.21e-06	5.53e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.21e-06	5.53e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—EP300—urinary bladder cancer	3.2e-06	5.52e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.18e-06	5.48e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.18e-06	5.47e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—urinary bladder cancer	3.16e-06	5.45e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.1e-06	5.35e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.08e-06	5.3e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	3.07e-06	5.28e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.06e-06	5.27e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.01e-06	5.19e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.96e-06	5.09e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	2.95e-06	5.07e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMS—urinary bladder cancer	2.94e-06	5.06e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.92e-06	5.03e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.92e-06	5.03e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTM1—urinary bladder cancer	2.91e-06	5.01e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NCOR1—urinary bladder cancer	2.91e-06	5.01e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.88e-06	4.96e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.84e-06	4.89e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.8e-06	4.82e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GPX1—urinary bladder cancer	2.78e-06	4.79e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.77e-06	4.77e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.75e-06	4.73e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.75e-06	4.73e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.74e-06	4.72e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ERCC2—urinary bladder cancer	2.73e-06	4.71e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—urinary bladder cancer	2.71e-06	4.66e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—urinary bladder cancer	2.66e-06	4.57e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.64e-06	4.55e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	2.63e-06	4.53e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.63e-06	4.52e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.61e-06	4.49e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.61e-06	4.49e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.59e-06	4.46e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.58e-06	4.45e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.58e-06	4.44e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—MTHFR—urinary bladder cancer	2.57e-06	4.42e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.55e-06	4.39e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.55e-06	4.39e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.54e-06	4.37e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.54e-06	4.37e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.5e-06	4.31e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.5e-06	4.3e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.46e-06	4.24e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.44e-06	4.2e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	2.41e-06	4.16e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.41e-06	4.15e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—urinary bladder cancer	2.41e-06	4.14e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.39e-06	4.12e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.38e-06	4.1e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.38e-06	4.1e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—urinary bladder cancer	2.32e-06	3.99e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.31e-06	3.97e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—urinary bladder cancer	2.3e-06	3.96e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	2.29e-06	3.95e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.28e-06	3.92e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.25e-06	3.88e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.24e-06	3.85e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—EP300—urinary bladder cancer	2.21e-06	3.8e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—EP300—urinary bladder cancer	2.19e-06	3.76e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	2.1e-06	3.62e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.1e-06	3.62e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.09e-06	3.61e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—urinary bladder cancer	2.08e-06	3.59e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.05e-06	3.53e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.01e-06	3.47e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—EP300—urinary bladder cancer	2.01e-06	3.46e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CREBBP—urinary bladder cancer	2e-06	3.45e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.87e-06	3.22e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.82e-06	3.14e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.8e-06	3.09e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.75e-06	3.02e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.71e-06	2.94e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.7e-06	2.94e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.65e-06	2.84e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—urinary bladder cancer	1.64e-06	2.82e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.64e-06	2.82e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.59e-06	2.73e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.57e-06	2.7e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.57e-06	2.7e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.5e-06	2.59e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.47e-06	2.54e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.47e-06	2.53e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.44e-06	2.48e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.44e-06	2.47e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—urinary bladder cancer	1.43e-06	2.46e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.39e-06	2.39e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.37e-06	2.36e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—EP300—urinary bladder cancer	1.36e-06	2.35e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.34e-06	2.31e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.28e-06	2.21e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.25e-06	2.16e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.22e-06	2.11e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.19e-06	2.06e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.17e-06	2.01e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.12e-06	1.94e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.12e-06	1.92e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.08e-06	1.86e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.84e-07	1.52e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.71e-07	1.33e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.36e-07	1.27e-05	CbGpPWpGaD
